首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

北美輸液設備市場規模和預測、區域佔有率、趨勢和成長機會分析報告範圍：按產品類型、應用、最終用戶和國家/地區

市場調查報告書

商品編碼

1558388

北美輸液設備市場規模和預測、區域佔有率、趨勢和成長機會分析報告範圍：按產品類型、應用、最終用戶和國家/地區

North America Infusion Devices Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User, and Country

出版日期: 2024年08月30日 | 出版商:

The Insight Partners | 英文 109 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美輸液設備市場規模預計將從 2023 年的 54.9415 億美元增至 2031 年的 91.1647 億美元。

根據美國人口普查局的數據，65歲及以上的美國人數量預計將從2022年的5,800萬增加到2050年的8,200萬，增幅為47%。此外，65 歲及以上年齡層佔總人口的比例預計將從 17% 上升至 23%。根據加拿大統計局的數據，到 2022 年，近 18.8% 的加拿大人年齡為 65 歲。近 20% 的加拿大人口年齡在 65 歲及以上。此外，人口預測表明，到 2068 年，21% 至 29% 的加拿大人可能會達到 65 歲或以上。

以下列出了對老年人進行輸液治療的一些主要好處。

補液和電解質平衡：由於口渴減少、某些藥物和腎功能變化等因素，老年人脫水的風險可能更高。靜脈輸液可以幫助老年人維持整體健康所需的水分和電解質水平。

營養支持與改善：老化使人體更難攝取正確的營養，增加罹患慢性病的風險。輸液療法為老年人提供了一種有效獲取必需礦物質、維生素和氨基酸的直接方法。

增強免疫功能：老年人的免疫系統可能需要額外的支持，因為他們更容易受到感染。輸液療法可以將維生素 C、鋅和穀胱甘肽等增強免疫力的營養素直接輸送到身體。

疼痛管理：許多老年人每天都要面對慢性疼痛，影響他們的生活品質。輸液療法可以透過將藥物直接輸送到血液中來快速有效地控制疼痛，從而緩解疼痛並減少發炎。

因此，不斷增加的老年人口推動了北美地區對輸液設備的需求。

市場參與者的策略性舉措

不同的市場參與者專注於策略發展，例如產品發布、合併、收購和合作，以開發先進的產品，幫助緩解糖尿病、癌症、慢性疼痛等慢性疾病的治療。以下是北美輸液設備市場的一些最新發展。

2024 年 4 月，Mackenzie Health 在加拿大推出了一項技術，允許靜脈 (IV) 藥物幫浦和病患電子病歷之間進行雙向資訊流。該技術稱為 BD Alaris EMR Interoperability，無需醫療保健專業人員對泵浦進行手動編程。它將輸液安全資訊傳送回 Epic EMR，從而降低管理錯誤的風險並在 EMR 中提供準確的輸液記錄。

2022年11月，美敦力公司宣佈在美國推出美敦力擴展輸液器。它是第一款也是唯一一款標有穿戴式長達 7 天的輸液器。輸液器是將胰島素從胰島素幫浦輸送到體內的管道，通常需要每兩到三天更換一次。

2022 年 5 月，Fresenius Kabi 收購了 Ivenix 及其先進的輸液泵技術，擴大了其先進輸液泵和醫療保健專業人員解決方案的產品組合，以滿足整個護理過程中的醫療保健需求。費森尤斯卡比也宣布，該公司已迅速擴大在美國的輸液治療產品組合，多種靜脈注射解決方案獲得 FDA 批准，預計其北卡羅來納州生產基地有資格向美國客戶提供靜脈注射解決方案。

2022 年 3 月，Fresenius Kabi 的無線 Agilia Connect 輸液系統獲得 FDA 510(k) 監管許可。該系統包括 Agilia 容量泵和 Agilia 注射泵，採用 Vigilant 軟體套件 - Vigilant Master Med 技術。這兩款泵都是首批按照 TIR101 標準獲得批准的泵，該標準由醫療器材促進協會 (AAMI) 於 2021 年制定。

產品批准、發布和策略合作數量的激增可能為未來的輸液設備市場創造利潤豐厚的機會。

基於最終用戶的見解

根據最終用戶，北美輸液設備市場分為醫院和專科診所、家庭護理機構、門診手術中心等。醫院和專科診所細分市場在 2023 年佔據主導地位。醫院和診所是患者完成診斷並選擇治療方案和替代方案的主要接觸點。醫院和診所的現有基礎設施可以為患有任何疾病的患者提供高品質的護理，因為他們可以獲得先進的醫療設備。醫院和診所預計將佔據相當大的市場佔有率，因為新興國家和已開發國家的大多數患者更喜歡去醫院解決健康相關問題。

由於輸液幫浦具有精確度、準確度和易用性等額外優點，輸液幫浦在醫院和診所得到了大規模使用。這些幫浦可用於化療、疼痛管理和糖尿病管理等應用，這些是患者住院時間較長或較短的主要原因。

WellSpan Health 和 BD 公司 CareFusion 共同宣佈在所有四家 WellSpan 醫院實施 Alaris 系統。 WellSpan 約克醫院是第一家啟用新型輸液設備以及電子健康記錄和輸液設備之間雙向互通性的醫院。

因此，輸液幫浦的優點和多種應用推動了北美醫院和診所輸液設備市場的成長。

根據應用，市場分為糖尿病、腫瘤學、疼痛管理、血液學、兒科、胃腸病學等。 2023 年，糖尿病細分市場佔據最大市場佔有率，預計 2023-2031 年期間複合年成長率最高。

根據最終用戶，北美輸液設備市場分為醫院和專科診所、家庭護理機構、門診手術中心等。醫院和專科診所細分市場在 2023 年佔據主導地位。

According to the US Census Bureau, the number of Americans aged 65 and above is expected to rise from 58 million in 2022 to 82 million by 2050, which is a 47% increase. Additionally, the share of the total population for the 65-and-older age group is projected to rise from 17% to 23%. According to Statistics Canada, in 2022, almost ~18.8% of Canadians were aged 65 years. Almost 20% of the Canadian population is aged 65 years and above. Furthermore, population projections suggest that 21% to 29% of Canadians could be aged 65 or above by 2068.

A few key benefits of infusion therapy administered in senior populations are listed below.

Rehydration and electrolyte balance: Dehydration can be a higher risk for seniors due to factors such as decreased thirst, certain medications, and changes in kidney function. IV fluids can help seniors maintain the necessary hydration and electrolyte levels for overall health.

Nutrition support and improvement: Aging makes it harder for human bodies to consume the right nutrients, increasing the risk of chronic illnesses. Infusion therapy provides a direct way for seniors to get essential minerals, vitamins, and amino acids efficiently.

Immune function reinforcement: Immune systems of elderly people may need extra support, as they are more vulnerable to infections. Infusion therapy can deliver immune-boosting nutrients such as vitamin C, zinc, and glutathione directly to the body.

Pain management: Many seniors deal with chronic pain daily, affecting their quality of life. Infusion therapy can quickly and effectively manage pain by delivering medication directly into the bloodstream, providing relief and reducing inflammation.

Thus, the increasing geriatric population drives the demand for infusion devices across North America.

Strategic Initiatives by Market Players

Various market players focus on strategic developments such as product launches, mergers, acquisitions, and collaborations to develop advanced products that help ease the treatment of chronic disorders such as diabetes, cancer, chronic pain among others. Following are a few recent developments in the North America infusion devices market.

In April 2024, Mackenzie Health launched a technology in Canada that allows for two-way information flow between an intravenous (IV) medication pump and a patient's electronic medical record. The technology, known as BD Alaris EMR Interoperability, eliminates the need for healthcare professionals to manually program pumps. It sends infusion safety information back to Epic EMR, reducing the risk of administration errors and providing an accurate infusion record in the EMR.

In November 2022, Medtronic plc announced the launch of Medtronic Extended infusion set in the US. It is the first and only infusion set labeled for up to seven-day wear. An infusion set is tubing that delivers insulin from an insulin pump to the body and usually needs to be changed every two to three days.

In May 2022, Fresenius Kabi acquired Ivenix and its advanced infusion pump technology, expanding its portfolio of advanced infusion pumps and solutions for healthcare professionals to address healthcare needs across the care continuum. Fresenius Kabi also announced that it has rapidly expanded its infusion therapy portfolio in the US, obtaining FDA approvals for multiple IV solutions in anticipation of qualifying its North Carolina manufacturing site to supply the US customers with IV solutions.

In March 2022, Fresenius Kabi received 510(k) regulatory clearance from the FDA for its wireless Agilia Connect Infusion System. The system includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology. Both pumps are the first to be cleared following TIR101 standards, which were developed by the Association for the Advancement of Medical Instrumentation (AAMI) in 2021.

An upsurge in the number of product approvals, launches, and strategic collaborations is likely to create lucrative opportunities for the infusion devices market in the future.

End User-Based Insights

Based on end user, the North America infusion devices market is divided into hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others. The hospitals and specialty clinics segment dominated the market in 2023. The homecare settings segment is anticipated to register the highest CAGR during 2023-2031. Hospitals and clinics are primary contact points for patients to get their diagnosis done and opt for treatment options and alternatives. Available infrastructure in hospitals and clinics can provide high-quality care for patients suffering from any disease condition as they have access to advanced medical devices. The hospitals and clinics segment is projected to hold a considerable market share as a majority of patients in emerging nations and developed countries prefer visiting hospitals for health-related problems.

Infusion pumps are being used on a large scale in hospitals and clinics, owing to the additional benefits offered by the pumps such as precision, accuracy, and ease of use. The pumps can be used for applications such as chemotherapy, pain management, and diabetes management, which are the major reasons for patients being admitted for longer and shorter duration.

WellSpan Health and CareFusion, a BD company, jointly announced the implementation of the Alaris System across all four WellSpan hospitals. WellSpan York Hospital is the first hospital to go live with new infusion devices and bi-directional interoperability between the electronic health record and infusion device.

Hence, the benefits and the multiple applications of infusion pumps fuel the North America infusion devices market growth for the hospitals and clinics segment.

By application, the market is segmented into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others. The diabetes segment held the largest share of the market in 2023, and it is projected to register the highest CAGR in the market during 2023-2031.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Infusion Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Overview of Mainstream System for infusion Pumps by US
- 4.3.1 Syringe Infusion Pumps:
- 4.3.2 Volumetric Infusion Pumps:
4.4 List of Best-Selling infusion Pumps along with the Model Number

5. North America Infusion Devices Market - Key Market Dynamics

5.1 North America Infusion Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Cancer
- 5.2.2 Growing Geriatric Population
5.3 Market Restraints
- 5.3.1 Frequent Product Recalls of Infusion Devices
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Growing Technological Advancements
5.6 Impact of Drivers and Restraints:

6. North America Infusion Devices Market Analysis

6.1 North America Infusion Devices Market Revenue (US$ Million), 2021-2031
6.2 North America Infusion Devices Market Forecast and Analysis

7. North America Infusion Devices Market Analysis - by Product Type

7.1 Infusion Pumps
- 7.1.1 Overview
- 7.1.2 Infusion Pumps: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Infusion Sets
- 7.2.1 Overview
- 7.2.2 Infusion Sets: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Infusion Devices Market Analysis - by Application

8.1 Diabetes
- 8.1.1 Overview
- 8.1.2 Diabetes: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Oncology: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Hematology
- 8.4.1 Overview
- 8.4.2 Hematology: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Pediatrics
- 8.5.1 Overview
- 8.5.2 Pediatrics: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Gastroenterology
- 8.6.1 Overview
- 8.6.2 Gastroenterology: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Infusion Devices Market Analysis - by End User

9.1 Hospitals and Specialty Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Specialty Clinics: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Homecare Settings
- 9.2.1 Overview
- 9.2.2 Homecare Settings: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Infusion Devices Market - Country Analysis

10.1 North America
- 10.1.1 North America Infusion Devices Market Breakdown by Countries
- 10.1.2 North America Infusion Devices Market Revenue and Forecast and Analysis - by Country
  - 10.1.2.1 North America Infusion Devices Market Revenue and Forecast and Analysis - by Country
  - 10.1.2.2 United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 United States: North America Infusion Devices Market Breakdown by Product Type
    - 10.1.2.2.2 United States: North America Infusion Devices Market Breakdown by Infusion Pumps
    - 10.1.2.2.3 United States: North America Infusion Devices Market Breakdown by Infusion Sets
    - 10.1.2.2.4 United States: North America Infusion Devices Market Breakdown by Application
    - 10.1.2.2.5 United States: North America Infusion Devices Market Breakdown by End User
  - 10.1.2.3 Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 Canada: North America Infusion Devices Market Breakdown by Product Type
    - 10.1.2.3.2 Canada: North America Infusion Devices Market Breakdown by Infusion Pumps
    - 10.1.2.3.3 Canada: North America Infusion Devices Market Breakdown by Infusion Sets
    - 10.1.2.3.4 Canada: North America Infusion Devices Market Breakdown by Application
    - 10.1.2.3.5 Canada: North America Infusion Devices Market Breakdown by End User
  - 10.1.2.4 Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.4.1 Mexico: North America Infusion Devices Market Breakdown by Product Type
    - 10.1.2.4.2 Mexico: North America Infusion Devices Market Breakdown by Infusion Pumps
    - 10.1.2.4.3 Mexico: North America Infusion Devices Market Breakdown by Infusion Sets
    - 10.1.2.4.4 Mexico: North America Infusion Devices Market Breakdown by Application
    - 10.1.2.4.5 Mexico: North America Infusion Devices Market Breakdown by End User

11. North America Infusion Devices Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in North America Infusion Devices Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview
11.5 Company Positioning:

12. Company Profiles

12.1 Becton Dickinson and Co
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Fresenius Kabi AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 B Braun SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 CODAN US Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Elimedical Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 ICU Medical Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 BPL Medical Technologies Pvt Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Nipro Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 KD Scientific Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Medtronic Plc
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Zimed Healthcare Ltd
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Terumo Corp
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Eitan Medical Ltd
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 Polymedicure
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
12.16 Moog Inc
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Infusion Devices Market Segmentation
Table 2. North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 4. North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 5. North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Country
Table 7. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 8. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Pumps
Table 9. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Sets
Table 10. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 11. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 12. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 13. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Pumps
Table 14. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Sets
Table 15. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 16. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 17. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 18. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Pumps
Table 19. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Sets
Table 20. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 21. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 22. Recent Organic Growth Strategies in North America Infusion Devices Market
Table 23. Recent Inorganic Growth Strategies in the North America Infusion Devices Market
Table 24. Glossary of Terms, North America Infusion Devices Market

List Of Figures

Figure 1. North America Infusion Devices Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Estimated Number of New Cancer Cases, US, 2024
Figure 4. Statistics of Incidence of Cancer at Glance, Canada, 2022
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Infusion Devices Market Revenue (US$ Million), 2021-2031
Figure 7. North America Infusion Devices Market Share (%) - by Product Type, 2023 and 2031
Figure 8. Infusion Pumps: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 9. Infusion Sets: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 10. North America Infusion Devices Market Share (%) - by Application, 2023 and 2031
Figure 11. Diabetes: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 12. Oncology: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 13. Pain Management: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 14. Hematology: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 15. Pediatrics: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 16. Gastroenterology: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 17. Others: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 18. North America Infusion Devices Market Share (%) - by End User, 2023 and 2031
Figure 19. Hospitals and Specialty Clinics: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 20. Homecare Settings: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 21. Ambulatory Surgical Centers: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 22. Others: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 23. North America Infusion Devices Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 24. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
Figure 25. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Growth Strategies in North America Infusion Devices Market